FindTrial
Sign In

Phacoemulsification Cataract Extraction Combine With Ex-Press Implantation in Primary Angle Closure Glaucoma: a Randomized Controlled Trial

Phacoemulsification Cataract Extraction Combine With Ex-Press Implantation in Primary Angle Closure Glaucoma: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007209
Enrollment
Unknown
Registered
2015-10-12
Start date
2015-11-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

Two groups:phacoemulsification cataract extraction combine with Ex-Press implantation versus trabeculectomy

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Primary angle closure glaucoma: 1) Intraocular pressure (IOP) 21mmHg; 2) Anterior chamber angle closure (invisible trabecular meshwork through gonioscope)>=180 degree and/or combine with PAS 3) Glaucomatous optic nerve damage and visual field defect; Cataract 1) Visible phacoscotasmus under slit lamp, Emery Grading>= Grade II (yellow or yellow-white lens nucleus); 2) Best corrected visual acuity (BCVA) <=0.5.

Exclusion criteria

Exclusion criteria: 1) Secondary glaucoma or other diseases which cause vision loss and retinal nerve fiber layer (RNFL) damage; 2) History of intraocular surgery or trauma; 3) Refused to sign informed consent; 4) Those who cannot complete 1-year follow-up.

Design outcomes

Primary

MeasureTime frame
safety and efficiency;—

Contacts

Public ContactGuo Wenyi
wyguo@163.com+86 13816880563

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026